Avoid Clinical Manufacturing Pitfalls With These Tech Transfer Best Practices

Ensure a smooth transition from development to manufacturing by implementing a strategic tech transfer process. This article outlines key practices for effective communication, collaboration, and risk mitigation between biotech companies and CDMOs.

Moving a biopharmaceutical product from development to clinical trial manufacturing can be a daunting task. A successful tech transfer, however, can streamline this process and save both time and money. This article explores the importance of clear communication and collaboration between biotech companies and their contract development and manufacturing organizations (CDMOs).

We delve into the critical steps of tech transfer, from selecting the right CDMO partner to navigating potential supply chain risks. By outlining best practices for program management, process development, and workflow handoffs, this article provides a roadmap to a successful tech transfer for your next clinical biomanufacturing program.